NKTR - Nektar Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

NKTR is currently covered by 9 analysts with an average price target of $148.8. This is a potential upside of $116.26 (357.28%) from yesterday's end of day stock price of $32.54.

Nektar Therapeutics's activity chart (see below) currently has 175 price targets and 193 ratings on display. The stock rating distribution of NKTR is 80.77% BUY and 19.23% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 43.12% of the time, taking 224.55 days on average.

Highest price target for NKTR is $192, Lowest price target is $50, average price target is $148.8.

Most recent stock forecast was given by JULIAN HARRISON from BTIG on 09-Oct-2026. First documented stock forecast 28-Jul-2014.

Currently out of the existing stock ratings of NKTR, 21 are a BUY (80.77%), 5 are a HOLD (19.23%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Sep-2024

$178

$140.73 (377.60%)

$178

1 months 11 days ago
(09-Oct-2026)

2/10 (20%)

$136.83 (332.35%)

257

Buy Since 10-Dec-2024

$185

$147.73 (396.38%)

$185

1 months 18 days ago
(02-Oct-2026)

2/7 (28.57%)

$141.42 (324.51%)

420

Hold Since 24-Mar-2026

$50

$12.73 (34.16%)

$80

1 months 28 days ago
(23-Sep-2026)

3/4 (75%)

$-7.66 (-13.28%)

4

Hold Since 21-Aug-2026

$65

$27.73 (74.40%)

2 months 30 days ago
(21-Aug-2026)

6/11 (54.55%)

$-9.02 (-12.19%)

107

Buy Since 04-Nov-2024

$192

$154.73 (415.16%)

$105

6 months 12 days ago
(08-May-2026)

1/3 (33.33%)

$110.11 (134.46%)

532

Show more analysts

Please expand the browser size to see the chart

What is NKTR (Nektar Therapeutics) average time for price targets to be met?

On average it took 225 days for the stock forecasts to be reached, with an average price target met ratio of 43.12%.

Which analyst most recently updated their price target on NKTR (Nektar Therapeutics)?

Julian Harrison

Which analyst has the most public recommendations on NKTR (Nektar Therapeutics)?

Julian Harrison works at BTIG and has 5 price targets and 6 ratings on NKTR

Which analyst is the currently most bullish on NKTR (Nektar Therapeutics)?

Corey Davis with the highest potential upside of $1762.73

Which analyst is the currently most reserved on NKTR (Nektar Therapeutics)?

Chris Shibutani with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?